ZNF28
gene geneOn this page
Also known as KOX24DKFZp781D0275
Summary
ZNF28 (zinc finger protein 28, HGNC:13073) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 28 (P17035). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7576 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 150 total
- MANE Select transcript:
NM_006969
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13073 |
| Approved symbol | ZNF28 |
| Name | zinc finger protein 28 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX24, DKFZp781D0275 |
| Ensembl gene | ENSG00000198538 |
| Ensembl biotype | protein_coding |
| OMIM | 620466 |
| Entrez | 7576 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000339844, ENST00000391783, ENST00000438150, ENST00000457749, ENST00000464469, ENST00000542421, ENST00000594602, ENST00000596559, ENST00000868404
RefSeq mRNA: 8 — MANE Select: NM_006969
NM_001369761, NM_001369762, NM_001369763, NM_001369764, NM_001369765, NM_001369766, NM_001369768, NM_006969
CCDS: CCDS33093, CCDS92676, CCDS92677
Canonical transcript exons
ENST00000457749 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001471343 | 52821586 | 52821633 |
| ENSE00003545254 | 52817944 | 52818031 |
| ENSE00003671511 | 52808007 | 52808133 |
| ENSE00003680409 | 52797408 | 52801702 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 86.06.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6436 / max 14.6347, expressed in 395 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182535 | 0.6436 | 395 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| islet of Langerhans | UBERON:0000006 | 86.06 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.06 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.82 | gold quality |
| endometrium | UBERON:0001295 | 83.75 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.40 | gold quality |
| cortical plate | UBERON:0005343 | 82.38 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.89 | gold quality |
| bone marrow cell | CL:0002092 | 80.85 | gold quality |
| rectum | UBERON:0001052 | 80.72 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.13 | gold quality |
| ventricular zone | UBERON:0003053 | 79.82 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 79.72 | gold quality |
| tonsil | UBERON:0002372 | 79.62 | gold quality |
| pancreas | UBERON:0001264 | 79.23 | gold quality |
| granulocyte | CL:0000094 | 78.22 | gold quality |
| leukocyte | CL:0000738 | 78.20 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.01 | gold quality |
| monocyte | CL:0000576 | 77.93 | gold quality |
| placenta | UBERON:0001987 | 77.82 | gold quality |
| adrenal gland | UBERON:0002369 | 77.72 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.59 | gold quality |
| duodenum | UBERON:0002114 | 77.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.45 | gold quality |
| kidney | UBERON:0002113 | 77.17 | gold quality |
| bone marrow | UBERON:0002371 | 77.08 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 76.97 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.93 | gold quality |
| lymph node | UBERON:0000029 | 76.85 | gold quality |
| gall bladder | UBERON:0002110 | 76.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.88 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
145 targeting ZNF28, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 28 — P17035 (reviewed: P17035)
Alternative names: Zinc finger protein KOX24
All UniProt accessions (5): C9K0H3, P17035, F8WBV3, M0QXU3, M0R0U4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17035-1 | 1 | yes |
| P17035-2 | 2 |
RefSeq proteins (8): NP_001356690, NP_001356691, NP_001356692, NP_001356693, NP_001356694, NP_001356695, NP_001356697, NP_008900* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (34 total): zinc finger region 18, sequence conflict 8, sequence variant 3, cross-link 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17035-F1 | 69.35 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 89, 428
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 79 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ELF2_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF350_TARGET_GENES, ZNF362_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR548AJ_3P_MIR548X_3P, MIR4698, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
352 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF28 | A6NLF2 | A6NLF2 | 515 |
| ZNF28 | A0A087WTG0 | A0A087WTG0 | 507 |
| ZNF28 | NBPF26 | B4DH59 | 507 |
| ZNF28 | CREG2 | Q8IUH2 | 459 |
| ZNF28 | SREK1IP1 | Q8N9Q2 | 457 |
| ZNF28 | SFXN3 | Q9BWM7 | 450 |
| ZNF28 | LEMD3 | Q9Y2U8 | 435 |
| ZNF28 | WIPF1 | O43516 | 425 |
| ZNF28 | INSYN2B | A6NMK8 | 419 |
| ZNF28 | P2RX1 | P51575 | 417 |
| ZNF28 | GNG12 | Q9UBI6 | 396 |
| ZNF28 | FAM124A | Q86V42 | 390 |
| ZNF28 | PDE6B | P35913 | 387 |
| ZNF28 | CCDC43 | Q96MW1 | 376 |
| ZNF28 | PMP2 | P02689 | 363 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAPK6 | HERC2 | psi-mi:“MI:0914”(association) | 0.840 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF28 | TCAF1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| PURG | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (10): ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-RNA), ZNF28 (Affinity Capture-RNA), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS), ZNF28 (Affinity Capture-MS)
ESM2 similar proteins: A2VDP4, A6NHJ4, O94892, P0CJ79, P17014, P17021, P17025, P17032, P17035, P18733, P51508, P51814, Q06730, Q06732, Q09FC8, Q0VGE8, Q14586, Q32M78, Q3MIS6, Q5JVG2, Q5R4K8, Q5R9S5, Q5RBQ3, Q5RCJ2, Q5RER9, Q5TYW1, Q5VIY5, Q6P560, Q6PDB4, Q6ZMW2, Q6ZN06, Q6ZNA1, Q76KX8, Q7L2R6, Q86Y25, Q8N184, Q8N823, Q8N883, Q8N8J6, Q8NEP9
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
150 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 127 |
| Likely benign | 11 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1669 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52808046:C:A | donor_gain | 1.0000 |
| 19:52818027:CAATC:C | acceptor_gain | 1.0000 |
| 19:52818032:C:CC | acceptor_gain | 1.0000 |
| 19:52849081:CCTCA:C | donor_loss | 1.0000 |
| 19:52849082:CTCAC:C | donor_loss | 1.0000 |
| 19:52849083:TCA:T | donor_loss | 1.0000 |
| 19:52849084:CA:C | donor_loss | 1.0000 |
| 19:52849085:AC:A | donor_gain | 1.0000 |
| 19:52849086:CC:C | donor_gain | 1.0000 |
| 19:52849126:C:A | donor_gain | 1.0000 |
| 19:52849210:GACC:G | acceptor_gain | 1.0000 |
| 19:52849211:ACCC:A | acceptor_loss | 1.0000 |
| 19:52849212:CC:C | acceptor_gain | 1.0000 |
| 19:52849213:CC:C | acceptor_gain | 1.0000 |
| 19:52849213:CCTGA:C | acceptor_loss | 1.0000 |
| 19:52849214:C:A | acceptor_loss | 1.0000 |
| 19:52854252:TCTCA:T | donor_loss | 1.0000 |
| 19:52854253:CTCA:C | donor_loss | 1.0000 |
| 19:52854254:TCA:T | donor_loss | 1.0000 |
| 19:52854255:CA:C | donor_loss | 1.0000 |
| 19:52854256:ACCTG:A | donor_loss | 1.0000 |
| 19:52854257:C:A | donor_loss | 1.0000 |
| 19:52854341:CAATC:C | acceptor_gain | 1.0000 |
| 19:52854344:TCC:T | acceptor_loss | 1.0000 |
| 19:52854346:C:CC | acceptor_gain | 1.0000 |
| 19:52854346:CTG:C | acceptor_loss | 1.0000 |
| 19:52854347:T:C | acceptor_loss | 1.0000 |
| 19:52808045:T:TA | donor_gain | 0.9900 |
| 19:52808130:GACC:G | acceptor_gain | 0.9900 |
| 19:52808132:CC:C | acceptor_gain | 0.9900 |
AlphaMissense
4829 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:52800081:G:C | F588L | 0.997 |
| 19:52800081:G:T | F588L | 0.997 |
| 19:52800083:A:G | F588L | 0.997 |
| 19:52799745:G:C | F700L | 0.996 |
| 19:52799745:G:T | F700L | 0.996 |
| 19:52799747:A:G | F700L | 0.996 |
| 19:52799997:G:C | F616L | 0.996 |
| 19:52799997:G:T | F616L | 0.996 |
| 19:52799999:A:G | F616L | 0.996 |
| 19:52799829:A:C | F672L | 0.995 |
| 19:52799829:A:T | F672L | 0.995 |
| 19:52799831:A:G | F672L | 0.995 |
| 19:52800165:G:C | F560L | 0.995 |
| 19:52800165:G:T | F560L | 0.995 |
| 19:52800167:A:G | F560L | 0.995 |
| 19:52800333:G:C | F504L | 0.995 |
| 19:52800333:G:T | F504L | 0.995 |
| 19:52800335:A:G | F504L | 0.995 |
| 19:52799913:G:C | F644L | 0.994 |
| 19:52799913:G:T | F644L | 0.994 |
| 19:52799915:A:G | F644L | 0.994 |
| 19:52800417:G:C | F476L | 0.994 |
| 19:52800417:G:T | F476L | 0.994 |
| 19:52800419:A:G | F476L | 0.994 |
| 19:52800501:A:C | F448L | 0.994 |
| 19:52800501:A:T | F448L | 0.994 |
| 19:52800503:A:G | F448L | 0.994 |
| 19:52800054:A:C | H597Q | 0.993 |
| 19:52800054:A:T | H597Q | 0.993 |
| 19:52800585:A:C | F420L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000023557 (19:52797426 A>C), RS1000077423 (19:52797694 A>C,T), RS1000097013 (19:52798556 T>C), RS1000150928 (19:52798254 C>T), RS1000457592 (19:52823011 A>C), RS1000723246 (19:52818318 T>C), RS1000849284 (19:52823198 A>C), RS1000863357 (19:52812867 A>T), RS1000918514 (19:52818661 C>A,G,T), RS1000963577 (19:52818521 T>C), RS1000978818 (19:52808629 C>A,G,T), RS1001096193 (19:52814206 C>A,G), RS1001247687 (19:52814317 A>G), RS1001305172 (19:52820501 G>A), RS1001315391 (19:52812538 G>A)
Disease associations
OMIM: gene MIM:620466 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002337_22 | Amyotrophic lateral sclerosis (sporadic) | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| sulforaphane | increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Arsenic Trioxide | increases expression, affects cotreatment | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tretinoin | increases expression, affects cotreatment | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): sporadic amyotrophic lateral sclerosis